NEWS AND INSIGHTS
Company news and perspectives
Company announcements, industry commentary and plain-language explanations of DNA nanotechnology and non-viral gene delivery. Peer-reviewed research and conference material are listed separately on the science and publications page.
AACR – 2024 – Gene Delivery Poster
AACR – 2024 – Drug Delivery Poster
Current State of Antibody Drug Conjugates: A Look into the Future with DNA Origami Nanobots
Current State of Antibody Drug Conjugates: A Look into the Future with DNA Origami Nanobots Antibody Drug Conjugates (ADCs) have emerged as a beacon of hope...
The Current State of Gene Delivery: Promise and Limitations
The Current State of Gene Delivery: Promise and Limitations Gene delivery holds transformative potential for the treatment of human disease. As our...
Precision Medicine: The Pioneers and How DNA Nanobots Could Take It to the Next Level
Precision Medicine: The Pioneers and How DNA Origami Could Take It to the Next Level Precision medicine, an approach that tailors medical treatments to...
The Current State of Drug Delivery Using Nanotechnology: A Case for DNA Nanobots
The Current State of Drug Delivery Using Nanotechnology: A Case for DNA Nanobots In recent years, nanotechnology has seen extensive applications across...
Introduction to DNA Nanobots: A Beginner’s Guide to What DNA Origami Nanobots Are and How They Can Revolutionize Drug Delivery
Introduction to DNA Origami Nanobots: A Beginner's Guide to What DNA Nanobots Are and How They Can Revolutionize Drug Delivery Advancements in nanotechnology...
2023 – AACR Poster
DNA Nanobots for Vaccine Delivery
by Christopher R. Lucas, PhD March 29, 2023 Vaccination against tumor antigens is a promising strategy for both cancer prevention and safe treatment, mediated...
Looking for the science?
Peer-reviewed research, company-reported preclinical results and conference material are kept separate from company news.